Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Landos Biopharma Inc (was acquired by AbbVie Inc. (NYSE: ABBV) on 25/03/2024) (LABP)

  • Event
  • June 21, 2022, 20:20 UTC
  • 16
  • 1 comments

(99% Neutral) Landos Biopharma, Inc. (LABP) Announces New Board Appointment

Comment Full text

Novavax Inc (NVAX)

  • Event
  • June 21, 2022, 20:16 UTC
  • 16
  • 1 comments

(99% Neutral) NOVAVAX, INC. (NVAX) Announces New Board Appointment

Comment Full text

Revolution Medicines Inc (RVMD)

  • Event
  • June 21, 2022, 20:16 UTC
  • 15
  • 1 comments

(99% Neutral) REVOLUTION MEDICINES, INC. (RVMD) Announces Regulatory Update

Comment Full text

Selecta Biosciences Inc (SELB)

  • Event
  • June 21, 2022, 20:15 UTC
  • 16
  • 1 comments

(99% Neutral) SELECTA BIOSCIENCES, INC. (SELB) Announces Executive Changes

Comment Full text

Morphic Therapeutic (MORF)

  • Event
  • June 21, 2022, 20:15 UTC
  • 16
  • 1 comments

(50% Neutral) Morphic Holding, Inc. (MORF) Announces Business Combination

Comment Full text

Acumen Pharmaceuticals Inc (ABOS)

  • Event
  • June 21, 2022, 20:07 UTC
  • 16
  • 1 comments

(99% Neutral) Acumen Pharmaceuticals, Inc. (ABOS) Files Form 8-K

Comment Full text

Gritstone Oncology Inc (GRTS)

  • Event
  • June 21, 2022, 20:02 UTC
  • 16
  • 1 comments

(99% Neutral) Gritstone bio, Inc. (GRTS) Announces Regulatory Update

Comment Full text

Taysha Gene Therapies (TSHA)

  • Event
  • June 21, 2022, 20:01 UTC
  • 16
  • 1 comments

(99% Neutral) Taysha Gene Therapies, Inc. (TSHA) Files Form 8-K

Comment Full text

Alector Inc (ALEC)

  • Event
  • June 21, 2022, 20:01 UTC
  • 16
  • 1 comments

(99% Neutral) Alector, Inc. (ALEC) Announces Regulatory Update

Comment Full text

Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX)

  • Event
  • June 21, 2022, 20:01 UTC
  • 16
  • 1 comments

(99% Neutral) Turning Point Therapeutics, Inc. (TPTX) Announces Regulatory Update

Comment Full text
  • Previous
  • 328
  • 329
  • 330
  • 331
  • 332
  • Next

Search

News categories

  • Technical Exchange News(11620)
  • Event(3800)
  • SEC News(223088)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(139900)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin